OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion

Publication date

2021-03-18T09:33:27Z

2021-03-18T09:33:27Z

2019

2021-03-18T09:33:27Z

Abstract

Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem.

Document Type

Article


Published version

Language

English

Publisher

Sociedad Española de Farmacia Hospitalaria

Related items

Reproducció del document publicat a: https://doi.org/10.7399/fh.11170

Farmacia Hospitalaria, 2019

https://doi.org/10.7399/fh.11170

Recommended citation

This citation was generated automatically.

Rights

cc by-nc-sa (c) Sociedad Española de Farmacia Hospitalaria, 2019

http://creativecommons.org/licenses/by-nc-sa/3.0/es/